Literature DB >> 30190823

Barriers to risk-understanding and risk-reduction behaviors among individuals with a family history of melanoma.

Laura Fitzpatrick1,1, Jennifer L Hay1,2,1,2.   

Abstract

Family members of melanoma patients are often called upon to provide support, ranging from monetary to medical assistance. Consanguineal relatives of melanoma patients are also at greater risk of developing the disease themselves. However, as a group, they have limited understanding of their melanoma risk and they demonstrate inadequate primary and secondary prevention behaviors. The optimal intervention strategies for improving the consistent use of such behaviors (i.e., improving rates of sun-protection behaviors and screening) remains unclear, necessitating further research.

Entities:  

Keywords:  CDKN2A; family history; first-degree relatives; melanoma

Year:  2014        PMID: 30190823      PMCID: PMC6094692          DOI: 10.2217/mmt.14.24

Source DB:  PubMed          Journal:  Melanoma Manag        ISSN: 2045-0885


  41 in total

1.  Sun-protective behavior among individuals with a family history of melanoma.

Authors:  Lora M Azzarello; Sophie Dessureault; Paul B Jacobsen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-01       Impact factor: 4.254

2.  Melanoma genetic counseling and test reporting improve screening adherence among unaffected carriers 2 years later.

Authors:  Lisa G Aspinwall; Jennifer M Taber; Samantha L Leaf; Wendy Kohlmann; Sancy A Leachman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-15       Impact factor: 4.254

3.  Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota.

Authors:  Kurtis B Reed; Jerry D Brewer; Christine M Lohse; Kariline E Bringe; Crystal N Pruitt; Lawrence E Gibson
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

4.  Communication about family members' risk of melanoma: self-reported practices of dermatologists in the United States.

Authors:  Susan A Oliveria; Maureen K Heneghan; Allan C Halpern; Jennifer L Hay; Alan C Geller
Journal:  Arch Dermatol       Date:  2012-05

5.  Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome.

Authors:  Lisa G Aspinwall; Jennifer M Taber; Samantha L Leaf; Wendy Kohlmann; Sancy A Leachman
Journal:  Psychooncology       Date:  2011-10-07       Impact factor: 3.894

6.  Sun protection practices among offspring of women with personal or family history of skin cancer.

Authors:  Alan C Geller; Daniel R Brooks; Graham A Colditz; Howard K Koh; A Lindsay Frazier
Journal:  Pediatrics       Date:  2006-04       Impact factor: 7.124

7.  Genetic counseling in melanoma.

Authors:  Celia Badenas; Paula Aguilera; Joan A Puig-Butillé; Cristina Carrera; Josep Malvehy; Susana Puig
Journal:  Dermatol Ther       Date:  2012 Sep-Oct       Impact factor: 2.851

8.  Sun protection and skin surveillance practices among relatives of patients with malignant melanoma: prevalence and predictors.

Authors:  Sharon Manne; Nicole Fasanella; Jennifer Connors; Briana Floyd; Hao Wang; Stuart Lessin
Journal:  Prev Med       Date:  2004-07       Impact factor: 4.018

9.  Skin self-examination of persons from families with familial atypical multiple mole melanoma (FAMMM).

Authors:  Ilse Mesters; Lodie Jonkman; Hans Vasen; Hein de Vries
Journal:  Patient Educ Couns       Date:  2008-11-20

10.  Sun protection and sunbathing practices among at-risk family members of patients with melanoma.

Authors:  Sharon L Manne; Elliot J Coups; Paul B Jacobsen; Michael Ming; Carolyn J Heckman; Stuart Lessin
Journal:  BMC Public Health       Date:  2011-02-21       Impact factor: 3.295

View more
  1 in total

1.  A systematic review and synthesis of qualitative and quantitative studies evaluating provider, patient, and health care system-related barriers to diagnostic skin cancer examinations.

Authors:  Maleka Najmi; Ashley E Brown; Sarah R Harrington; David Farris; Sarah Sepulveda; Kelly C Nelson
Journal:  Arch Dermatol Res       Date:  2021-04-28       Impact factor: 3.017

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.